Cormorant Asset Management, LP 13D/13G Filings for Forma Therapeutics Holdings, Inc. (FMTX)

Cormorant Asset Management, LP 13D and 13G filings for Forma Therapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
3:13 pm
Purchase
2021-12-3113GFORMA THERAPEUTICS HLDGS INC
FMTX
Cormorant Asset Management, LP4,639,998
9.790%
179,998increase
(+4.04%)
Filing